dc.contributor.author | Sut, Necdet | |
dc.contributor.author | Mert, A | |
dc.contributor.author | Ozbay, Gülşen | |
dc.contributor.author | Tabak, F | |
dc.contributor.author | Midilli, Kenan | |
dc.contributor.author | Ozaras, Reşat | |
dc.contributor.author | Canbakan, B | |
dc.contributor.author | Senturk, H | |
dc.contributor.author | Akdogan, M | |
dc.contributor.author | Tahan, V | |
dc.date.accessioned | 2021-03-03T15:48:45Z | |
dc.date.available | 2021-03-03T15:48:45Z | |
dc.date.issued | 2006 | |
dc.identifier.citation | Canbakan B., Senturk H., Tabak F., Akdogan M., Tahan V., Mert A., Sut N., Ozaras R., Midilli K., Ozbay G., "Efficacy of interferon alpha-2b and lamivudine combination treatment in comparison to interferon alpha-2b alone in chronic delta hepatitis: A randomized trial", JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, cilt.21, sa.4, ss.657-663, 2006 | |
dc.identifier.issn | 0815-9319 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_40ea6d74-1474-45d0-99a5-c0dec60ade69 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/47374 | |
dc.identifier.uri | https://doi.org/10.1111/j.1440-1746.2006.04082.x | |
dc.description.abstract | Background and Aim: Delta hepatitis is characterized by rapidly progressive liver disease with adverse prognosis in most patients. Patients benefit from high doses and prolonged courses of interferon (IFN) therapy; however, lamivudine as a single agent has been disappointing. Data relating to the efficacy of IFN and lamivudine in combination is limited. The aim of this study was to test the efficacy of IFN-alpha 2b and lamivudine combination treatment in comparison to IFN-alpha 2b alone in patients with chronic delta hepatitis. | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Gastroenteroloji-(Hepatoloji) | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | GASTROENTEROLOJİ VE HEPATOLOJİ | |
dc.title | Efficacy of interferon alpha-2b and lamivudine combination treatment in comparison to interferon alpha-2b alone in chronic delta hepatitis: A randomized trial | |
dc.type | Makale | |
dc.relation.journal | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | |
dc.contributor.department | , , | |
dc.identifier.volume | 21 | |
dc.identifier.issue | 4 | |
dc.identifier.startpage | 657 | |
dc.identifier.endpage | 663 | |
dc.contributor.firstauthorID | 41156 | |